Key points are not available for this paper at this time.
This document is an update to the 2011 Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2C9 and VKORC1 genotypes and warfarin dosing. Evidence from the published literature is presented for CYP2C9, VKORC1, CYP4F2, and rs12777823 genotype-guided warfarin dosing to achieve a target international normalized ratio of 2-3 when clinical genotype results are available. In addition, this updated guideline incorporates recommendations for adult and pediatric patients that are specific to continental ancestry.
Building similarity graph...
Analyzing shared references across papers
Loading...
Johnson et al. (Wed,) studied this question.
synapsesocial.com/papers/69dcce271e43378fbd133761 — DOI: https://doi.org/10.1002/cpt.668
JA Johnson
University of Florida
KE Caudle
St. Jude Children's Research Hospital
Li Gong
Tianjin University of Commerce
Clinical Pharmacology & Therapeutics
Stanford University
University of Pennsylvania
University of Chicago
Building similarity graph...
Analyzing shared references across papers
Loading...